Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomecompanyBetamethasone 378-44-9 98%
Betamethasone
Betamethasone

Betamethasone 378-44-9 98%

Price Get Latest Price
Packge 1kg5kg10kg25kg
  • Min. Order:10kg
  • Time:2024-01-27

Product Details

  • Product NameBetamethasone
  • CAS No.378-44-9
  • EINECS No.206-825-4
  • MFC22H29FO5
  • MW392.47
  • InChIKeyUREBDLICKHMUKA-IVGDLNKNNA-N
  • AppearanceneatWhite to Off-White
  • storage temp.  0-6°C
  • Melting point 235-237°C
  • density 1.1283 (estimate)
  • Boiling point 568.2±50.0 °C(Predicted)
  • Water Solubility 58mg/L(25 ºC)

Company Profile Introduction

PRACHEM LABORATORIES PRIVATE LIMITED is an active pharmaceutical ingredients (API) manufacturing company based at Ahmedabad Gujarat, is in the business of development, production and marketing of research base Manufacturing cortico - steroids, hormones and vitamins API in category 5(f).  The PRACHEM LABORATORIES UNIT - I is in operation for Cortico steroids and vitamins manufacturing since 2007 at Plot No. 3109, GIDC Chhatral, Gandhinagar, with a view to develop a broad network in domestic market. As the fastest growing manufacture of Cortico steroids and vitamins APIs in Gujarat, Prachem Laboratories has been adhering to the business philosophy of providing the best products, the most efficient services since the established in 2007.  State of Art manufacturing facility is located at GIDC Chhatral, near Ahmedabad. The plant is approved by Food and Drug Administration of Gujarat and is divided into three sections for optimum results. The first unit is dedicated to manufacture Cortico-steroid. Parallely, the second unit manufactures Methylcobalamin and the third unit is dedicated to manufacture Hormone.

Prachem Laboratories

1Y Gujarat India
  • Since:2020-01-01
  • Address: Plot No. 3109, Phase 3, GIDC Chhatral, Chhatral, Gujarat-382729, India.
INQUIRY